BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25611834)

  • 1. Arterial stiffness in kidney transplantation: a single center case-control study comparing belatacept versus calcineurin inhibitor immunosuppressive based regimen.
    Melilli E; Bestard-Matamoros O; Manonelles-Montero A; Sala-Bassa N; Mast R; Grinyó-Boira JM; Cruzado JM
    Nefrologia; 2015; 35(1):58-65. PubMed ID: 25611834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential impact of belatacept and cyclosporine A on central aortic blood pressure and arterial stiffness after renal transplantation.
    Seibert FS; Steltzer J; Melilli E; Grannas G; Pagonas N; Bauer F; Zidek W; Grinyó J; Westhoff TH
    Clin Transplant; 2014 Sep; 28(9):1004-9. PubMed ID: 24974984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.
    Grinyó JM; Del Carmen Rial M; Alberu J; Steinberg SM; Manfro RC; Nainan G; Vincenti F; Jones-Burton C; Kamar N
    Am J Kidney Dis; 2017 May; 69(5):587-594. PubMed ID: 27889299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experience with belatacept rescue therapy in kidney transplant recipients.
    Brakemeier S; Kannenkeril D; Dürr M; Braun T; Bachmann F; Schmidt D; Wiesener M; Budde K
    Transpl Int; 2016 Nov; 29(11):1184-1195. PubMed ID: 27514317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept.
    Choi M; Bachmann F; Wu K; Lachmann N; Schmidt D; Brakemeier S; Duerr M; Kahl A; Eckardt KU; Budde K; Nickel P
    BMC Nephrol; 2020 Aug; 21(1):354. PubMed ID: 32819287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance Belatacept-Based Immunosuppression in Lung Transplantation Recipients Who Failed Calcineurin Inhibitors.
    Iasella CJ; Winstead RJ; Moore CA; Johnson BA; Feinberg AT; Morrell MR; Hayanga JWA; Lendermon EA; Zeevi A; McDyer JF; Ensor CR
    Transplantation; 2018 Jan; 102(1):171-177. PubMed ID: 28691954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcome of belatacept therapy in de novo kidney transplant recipients - a case-match analysis.
    Schwarz C; Mayerhoffer S; Berlakovich GA; Steininger R; Soliman T; Watschinger B; Böhmig GA; Eskandary F; König F; Mühlbacher F; Wekerle T
    Transpl Int; 2015 Jul; 28(7):820-7. PubMed ID: 25703346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes after Conversion to a Belatacept-Based Immunosuppression in Kidney Transplant Recipients.
    Divard G; Aubert O; Debiais-Deschamp C; Raynaud M; Goutaudier V; Sablik M; Sayeg C; Legendre C; Obert J; Anglicheau D; Lefaucheur C; Loupy A
    Clin J Am Soc Nephrol; 2024 May; 19(5):628-637. PubMed ID: 38265815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early conversion to belatacept after renal transplantation.
    Nair V; Liriano-Ward L; Kent R; Huprikar S; Rana M; Florman SS; Delaney VB; Menon MC; Sehgal V; Miko L; Khaim R; Benvenisty A; Lerner S; Arvelakis A; Wadhera V; Ames S; Shapiro R
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28267882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Belatacept prophylaxis against organ rejection in adult kidney-transplant recipients.
    Del Bello A; Marion O; Milongo D; Rostaing L; Kamar N
    Expert Rev Clin Pharmacol; 2016; 9(2):215-27. PubMed ID: 26691282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a change in immunosuppressive regimen with hemodynamic and inflammatory markers of cardiovascular disease after kidney transplantation.
    Yong K; Nguyen HD; Hii L; Chan DT; Boudville N; Messineo A; Lim EM; Dogra GK; Lim WH
    Am J Hypertens; 2013 Jul; 26(7):843-9. PubMed ID: 23443728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of intervention strategies that target arterial stiffness in end-stage renal disease: a systematic review protocol.
    Rodriguez RA; Shea B; Hae R; Burns KD
    Syst Rev; 2016 Jul; 5(1):118. PubMed ID: 27431798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to belatacept after lung transplantation: Report of 10 cases.
    Brugière O; Vallée A; Raimbourg Q; Peraldi MN; de Verdière SC; Beaumont L; Hamid A; Zrounba M; Roux A; Picard C; Parquin F; Glorion M; Oniszczuk J; Hertig A; Mal H; Bunel V
    PLoS One; 2023; 18(3):e0281492. PubMed ID: 36920935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Belatacept rescue conversion in kidney transplant recipients with vascular lesions (Banff cv score >2):  a retrospective cohort study.
    Bertrand D; Matignon M; Morel A; Ludivine L; Lemoine M; Hanoy M; Roy FL; Nezam D; Hamzaoui M; de Nattes T; Moktefi A; François A; Laurent C; Etienne I; Guerrot D
    Nephrol Dial Transplant; 2023 Feb; 38(2):481-490. PubMed ID: 35544123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients.
    Gungor O; Kircelli F; Carrero JJ; Hur E; Demirci MS; Asci G; Toz H
    Clin Nephrol; 2011 Jun; 75(6):491-6. PubMed ID: 21612751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Belatacept Rescue Therapy in Kidney Transplant Recipients With Vascular Lesions: A Case Control Study.
    Bertrand D; Cheddani L; Etienne I; François A; Hanoy M; Laurent C; Lebourg L; Le Roy F; Lelandais L; Loron MC; Godin M; Guerrot D
    Am J Transplant; 2017 Nov; 17(11):2937-2944. PubMed ID: 28707779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney transplantation improves arterial stiffness in patients with end-stage renal disease.
    Feng S; Wang H; Yang J; Hu X; Wang W; Liu H; Li H; Zhang X
    Int Urol Nephrol; 2020 May; 52(5):877-884. PubMed ID: 31925642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does belatacept improve outcomes for kidney transplant recipients? A systematic review.
    Talawila N; Pengel LH
    Transpl Int; 2015 Nov; 28(11):1251-64. PubMed ID: 25965549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with increased arterial stiffness in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Med Sci Monit; 2010 Jun; 16(6):CR301-6. PubMed ID: 20512094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of calcineurin inhibitors on pulse wave velocity in renal transplant recipients.
    Strózecki P; Adamowicz A; Włodarczyk Z; Manitius J
    Ren Fail; 2007; 29(6):679-84. PubMed ID: 17763162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.